Genome-wide analysis identifies a role for common copy number variants in specific language impairment

Simpson, Nuala H and Ceroni, Fabiola and Reader, Rose H and Covill, Laura E and Knight, Julian C and Hennessy, Elizabeth R and Bolton, Patrick F and Conti-Ramsden, Gina and O'Hare, Anne and Baird, Gillian and Fisher, Simon E and Newbury, Dianne F and Nudel, R and Monaco, AP and Simonoff, E and Bolton, PF and Pickles, A and Slonims, V and Dworzynski, K and Everitt, A and Clark, A and Watson, J and Seckl, J and Cowie, H and Cohen, W and Nasir, J. and Bishop, DVM and Simkin, Z (2015) Genome-wide analysis identifies a role for common copy number variants in specific language impairment. European Journal of Human Genetics, 23 (10). pp. 1370-1377. ISSN 1018-4813

[img]
Preview
Text (Simpson-etal-EJHG-2016-Genome-wide-analysis-identifies-a-role-for-common-copy-number-variants-in-specific)
Simpson_etal_EJHG_2016_Genome_wide_analysis_identifies_a_role_for_common_copy_number_variants_in_specific.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo

Download (368kB)| Preview

    Abstract

    An exploratory genome-wide copy number variant (CNV) study was performed in 127 independent cases with specific language impairment (SLI), their first-degree relatives (385 individuals) and 269 population controls. Language-impaired cases showed an increased CNV burden in terms of the average number of events (11.28 vs 10.01, empirical P=0.003), the total length of CNVs (717 vs 513 Kb, empirical P=0.0001), the average CNV size (63.75 vs 51.6 Kb, empirical P=0.0005) and the number of genes spanned (14.29 vs 10.34, empirical P=0.0007) when compared with population controls, suggesting that CNVs may contribute to SLI risk. A similar trend was observed in first-degree relatives regardless of affection status. The increased burden found in our study was not driven by large or de novo events, which have been described as causative in other neurodevelopmental disorders. Nevertheless, de novo CNVs might be important on a case-by-case basis, as indicated by identification of events affecting relevant genes, such as ACTR2 and CSNK1A1, and small events within known micro-deletion/-duplication syndrome regions, such as chr8p23.1. Pathway analysis of the genes present within the CNVs of the independent cases identified significant overrepresentation of acetylcholine binding, cyclic-nucleotide phosphodiesterase activity and MHC proteins as compared with controls. Taken together, our data suggest that the majority of the risk conferred by CNVs in SLI is via common, inherited events within a 'common disorder-common variant' model. Therefore the risk conferred by CNVs will depend upon the combination of events inherited (both CNVs and SNPs), the genetic background of the individual and the environmental factors.